共 291 条
[1]
Viviani S(2011)ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned N Engl J Med 365 203-212
[2]
Zinzani PL(2016)Adapted treatment guided by Interim PET-CT scan in advanced Hodgkin's lymphoma N Engl J Med 374 2419-2429
[3]
Rambaldi A(2017)Multicenter prospective escalation-deescalation PET-guided clinical study in classical type Hodgkin disease in the North-West of Russian Federation (RNWOHG-HD1): rationale and design Cell Ther Transplant 4 76-81
[4]
Brusamolino E(2002)Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Lancet 359 2065-2071
[5]
Levis A(1993)Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial Lancet 341 1051-1054
[6]
Bonfante V(1992)High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease J Clin Oncol 10 1086-1094
[7]
Johnson P(2007)Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma Hematol Oncol Clin North Am 21 943-960
[8]
Federico M(2006)Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma Biol Blood Marrow Transplant 12 1065-1072
[9]
Kirkwood A(2016)Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation Br J Haematol 175 440-447
[10]
Fosså A(2013)Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant Leuk Lymphoma 54 2531-2533